Concord Healthcare Schedules 11 May 2026 AGM; Proposes 20% Issuance Mandate, 10% Buyback Limit and No Final Dividend

Bulletin Express
Apr 15

Concord Healthcare Group Co., Ltd. will convene its Annual General Meeting (AGM) for the 2025 financial year on 11 May 2026 at 9:30 a.m. (Hong Kong time) at A1, 26th Floor, Hanwei Building East Area, No. 7 Guanghua Road, Chaoyang District, Beijing.

Key ordinary resolutions • Approval of the 2025 Directors’ Report, 2025 Annual Report and 2025 Environmental, Social and Governance Report. • Confirmation of directors’ remuneration for 2025 and proposed remuneration for 2026. • Re-appointment of the external auditor. • Endorsement of the 2025 Annual Results Announcement and related authorisations. • Appointment of an additional executive director and approval of that director’s 2026 remuneration. • No final dividend for the year ended 31 December 2025.

Key special resolutions • General mandate authorising the Board to issue, allot and/or deal with additional Domestic and/or H Shares up to 20% of the shares in issue as at the AGM date, capped at 156.73 million shares. • General mandate authorising the Board to repurchase H Shares on the Hong Kong Stock Exchange up to 10% of the H Shares in issue during the mandate period. The mandates will remain effective until the earlier of (i) the next AGM, (ii) 12 months after approval, or (iii) revocation by shareholders.

Shareholder arrangements • The H-share register will be closed from 6 May 2026 to 11 May 2026 (both days inclusive). Share transfers must be lodged with Computershare Hong Kong Investor Services Limited by 4:30 p.m. on 5 May 2026 to qualify for AGM attendance and voting. • Shareholders may appoint one or more proxies to vote by poll; completed proxy forms must be received at the designated addresses not less than 24 hours before the meeting.

Board composition at the notice date: Executive Directors – Dr. Yang Jianyu (Chairman), Ms. Fu Xiao, Mr. Chang Liang; Non-executive Directors – Mr. Wang Lei, Mr. Song Qingbao, Mr. Shi Botao; Independent Non-executive Directors – Ms. Li Xuemei, Mr. Sun Yansheng, Mr. Ng Kwok Yin.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10